首页> 外国专利> METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVORABLE REMODELING OF THE LEFT VENTRICLE OF THE HEART IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION WITH ST STENT ELEVATION WITHIN 6 MONTHS OF THE ONSET OF THE DISEASE

METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVORABLE REMODELING OF THE LEFT VENTRICLE OF THE HEART IN PATIENTS WITH ACUTE ANTERIOR MYOCARDIAL INFARCTION WITH ST STENT ELEVATION WITHIN 6 MONTHS OF THE ONSET OF THE DISEASE

机译:预测在发病前6个月内发生急性先天性心脏病并急性发作的患者中左心室发展不良的风险的方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, specifically to cardiology, rehabilitation, ultrasound diagnosis and therapy, and relates to method for predicting the risk of developing an unfavorable remodeling of the left ventricle of the heart in patients with acute anterior myocardial infarction with ST-segment elevation within 6 months from the onset of the disease. Essence of the method: in patients with acute myocardial infarction, the serum content of the soluble form of the stimulating growth factor-sST2 is determined in the first day. If the sST2 level is detected more than 40 ng/ml, the risk of unfavorable remodeling of the left ventricle is assessed as high. Proposed method allows to identify with sufficient accuracy a group of high risk of developing unfavorable LV remodeling in patients with acute myocardial infarction for dispensary follow-up, to assess the personal risk of LV remodeling progression and the possibility of CHF development in patients after acute anterior myocardial infarction with ST-segment elevation still at an early stage of disease manifestation and timely correct treatment tactics.;EFFECT: invention provides an increase in accuracy of prognosis of the course of the disease, allows assessing personal risk and prescribe appropriate pathogenetic preventive therapy aimed at inhibiting the activity of this marker.;1 cl, 2 ex
机译:发明领域本发明涉及医学,尤其涉及心脏病学,康复,超声诊断和治疗,并且涉及预测急性前壁心肌梗死患者发生心脏左心室重塑的风险的方法。发病后6个月内ST段抬高。方法的实质:在急性心肌梗死患者中,在第一天就测定其可溶性形式的刺激性生长因子-sST2的血清含量。如果检测到的sST2水平超过40 ng / ml,则左心室重塑的风险被评估为高。拟议的方法允许以足够的准确性准确地识别出一组急性心肌梗死患者发生左室重塑的高风险,以便进行必要的随访,以评估个人左室重塑进展的风险以及急性前路术后患者发生CHF的可能性ST段抬高的心肌梗塞仍处于疾病表现的早期阶段,并及时采取正确的治疗策略。效果:本发明提高了疾病进程的预后准确性,允许评估个人风险并针对患者制定适当的病原性预防疗法1 cl,2 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号